Rahbar K, Essler M, Pabst KM, Eiber M, et al. Safety and Survival Outcomes of Lutetium-177-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer with prior Radium-223 treatment: The RALU Study. J Nucl Med 2022 Oct 27. pii: jnumed.122.264456. doi: 10.2967/jnumed.122.264456.
PMID: 36302656